Protalix BioTherapeutics
PLX
PLX
83 hedge funds and large institutions have $26.8M invested in Protalix BioTherapeutics in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
13% less capital invested
Capital invested by funds: $30.9M → $26.8M (-$4.08M)
38% less call options, than puts
Call options by funds: $31K | Put options by funds: $50K
Holders
83
Holding in Top 10
–
Calls
$31K
Puts
$50K
Top Buyers
| 1 | +$593K | |
| 2 | +$573K | |
| 3 | +$317K | |
| 4 |
Goldman Sachs
New York
|
+$229K |
| 5 |
BlackRock
New York
|
+$196K |
Top Sellers
| 1 | -$344K | |
| 2 | -$209K | |
| 3 | -$132K | |
| 4 |
Renaissance Technologies
New York
|
-$107K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$105K |
